(Q35146924)

6 August 2017

1 reference

title

Immunobiologic consequences of assist devices (English)

1 reference

6 August 2017

Silviu Itescu

1

1 reference

6 August 2017

Michael Schuster

2

1 reference

6 August 2017

Elizabeth Burke

3

1 reference

6 August 2017

Jan Ankersmit

4

1 reference

6 August 2017

Alfred Kocher

5

1 reference

6 August 2017

Mario Deng

6

1 reference

6 August 2017

Ranjit John

7

1 reference

6 August 2017

Katherine Lietz

8

1 reference

6 August 2017

publication date

1 February 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

119-33, ix-x

1 reference

Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Tissue reaction and metal sensitivity. An animal study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Contact sensitization of mice to nickel sulphate and potassium dichromate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Concentration of Wear Products in Hair, Blood, and Urine after Total Hip Replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Clinical implications of hemodialysis membrane biocompatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Composition of polymer membranes for therapies of end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Transient adhesion of neutrophils to endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

beta 2-Microglobulin and granulocyte elastase.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Mobilization of an Intracellular Glycoprotein (Mac-1) on Monocytes and Granulocytes during Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Monocyte Phenotype and Interleukin-1 Production in Patients Undergoing Haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Mortality in dialysis patients: analysis of the causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Molecular approaches to the characterization of cell and blood/biomaterial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

How does HIV cause AIDS?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

The immunology of primary HIV infection: which immune responses control HIV replication?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Infection and apoptotic cell death of CD4+ T cells during an immune response to HIV-1-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Immunology. New clues to systemic lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

The apoptosis-1/Fas protein in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Implantable LVAD infections: implications for permanent use of the device

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

CD95 (Fas/APO-1) induces an increased phosphatidylserine synthesis that precedes its externalization during programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Systemic exposure to irradiated apoptotic cells induces autoantibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Deletion of C4A genes in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Human CD14 mediates recognition and phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Indirect recognition of donor HLA-DR peptides in organ allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

New strategies for early diagnosis of heart allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

1 reference

7 January 2021

Do B cells drive the diversification of immune responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation. Fluorescence-activated cell sorter analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Immunologically active proteins in intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

Linear regression analysis based on Buckley-James estimating equation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2802%2900135-2

7 January 2021

10.1016/S0733-8651(02)00135-2

Identifiers

DOI

1 reference

6 August 2017

1 reference